Back
Sonoco Products 10K Form
Sell
32
SON
Sonoco Products
Last Price:
54.20
Seasonality Move:
2.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | SON/Sonoco Products Quarterly |
| 2023-08-02 | 10Q | SON/Sonoco Products Quarterly |
| 2023-05-03 | 10Q | SON/Sonoco Products Quarterly |
| 2022-11-02 | 10Q | SON/Sonoco Products Quarterly |
| 2022-08-02 | 10Q | SON/Sonoco Products Quarterly |
| 2022-05-03 | 10Q | SON/Sonoco Products Quarterly |
Receive SON News And Ratings
See the #1 stock for the next 7 days that we like better than SON
SON Financial Statistics
Sales & Book Value
| Annual Sales: | $6.78B |
|---|---|
| Cash Flow: | $16.02M |
| Price / Cash Flow: | 12.53 |
| Annual Sales: | $24.78 |
| Price / Book: | 2.19 |
Profitability
| EPS (TTM): | 3.72000 |
|---|---|
| Net Income (TTM): | $367.98M |
| Gross Margin: | $1.44B |
| Return on Equity: | 15.41% |
| Return on Assets: | 5.13% |
Sonoco Products Earnings Forecast
Key Sonoco Products Financial Ratios
- The Gross Profit Margin over the past 40 years for SON is 21.17%.
- The Selling, General & Administrative Expenses for SON have been equal to 11.15% of Gross Profit Margin.
- The Research & Development expenses have been 0.42% of Revenue.
- The Interest Expense is 28.78% of Operating Income.
- The Net Earning history of SON is 7.00% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 27 years.
Sonoco Products Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Containers & Packaging |
| Sector: | Materials |
| Current Symbol: | SON |
| CUSIP: | 835495 |
| Website: | sonoco.com |
Debt
| Debt-to-Equity Ratio: | 1.24 |
|---|---|
| Current Ratio: | 1.3 |
| Quick Ratio: | 0.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.29 |
|---|---|
| Forward P/E Ratio: | 9.6 |
SON Technical Analysis vs Fundamental Analysis
Sell
32
Sonoco Products (SON)
is a Sell
Is Sonoco Products a Buy or a Sell?
-
Sonoco Products stock is rated a Sell
The current Sonoco Products [SON] share price is $54.21. The Score for SON is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.